MAM
ELV icon

Meeder Asset Management’s Elevance Health ELV Stock Holding History

Meeder Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.72M Sell
19,555
-476
-2% -$156K 0.33% 68
2025
Q4 		$7.02M Buy
20,031
+4,155
+26% +$1.4M 0.38% 58
2025
Q3 		$5.13M Buy
15,876
+15,825
+31,029% +$4.92M 0.29% 61
2025
Q2 		$19.8K Sell
51
-8,840
-99% -$3.56M ﹤0.01% 520
2025
Q1 		$3.87M Buy
8,891
+8,825
+13,371% +$3.54M 0.26% 64
2024
Q4 		$24.3K Sell
66
-2,203
-97% -$922K ﹤0.01% 489
2024
Q3 		$1.18M Sell
2,269
-42,761
-95% -$22.8M 0.08% 137
2024
Q2 		$24.4M Buy
45,030
+2,982
+7% +$1.58M 1.71% 15
2024
Q1 		$21.8M Buy
42,048
+23,668
+129% +$11.8M 1.38% 17
2023
Q4 		$8.67M Buy
18,380
+10,754
+141% +$4.97M 0.68% 37
2023
Q3 		$3.32M Sell
7,626
-3,624
-32% -$1.64M 0.26% 86
2023
Q2 		$5M Buy
11,250
+2,877
+34% +$1.33M 0.36% 64
2023
Q1 		$3.85M Buy
8,373
+2,077
+33% +$988K 0.31% 80
2022
Q4 		$3.23M Sell
6,296
-494
-7% -$251K 0.28% 94
2022
Q3 		$3.08M Buy
6,790
+1,114
+20% +$533K 0.18% 103
2022
Q2 		$2.74M Sell
5,676
-7,408
-57% -$3.66M 0.16% 121
2022
Q1 		$6.43M Buy
+13,084
New +$5.98M 0.31% 66
2021
Q4 		– Sell
-3,317
Closed -$1.24M – 1515
2021
Q3 		$1.24M Buy
3,317
+193
+6% +$73.3K 0.06% 233
2021
Q2 		$1.19M Buy
3,124
+385
+14% +$147K 0.06% 241
2021
Q1 		$983K Buy
2,739
+157
+6% +$50.5K 0.05% 274
2020
Q4 		$829K Sell
2,582
-22,950
-90% -$7.04M 0.18% 103
2020
Q3 		$6.86M Buy
25,532
+14,734
+136% +$3.96M 0.44% 51
2020
Q2 		$2.84M Buy
10,798
+9,143
+552% +$2.44M 0.18% 108
2020
Q1 		$376K Buy
1,655
+5
+0.3% +$1.36K 0.03% 400
2019
Q4 		$498K Buy
1,650
+508
+44% +$140K 0.03% 410
2019
Q3 		$274K Buy
1,142
+133
+13% +$36.4K 0.02% 534
2019
Q2 		$285K Buy
1,009
+488
+94% +$133K 0.02% 504
2019
Q1 		$149K Buy
521
+26
+5% +$7.52K 0.01% 606
2018
Q4 		$130K Sell
495
-1,153
-70% -$317K 0.01% 581
2018
Q3 		$452K Sell
1,648
-26,551
-94% -$6.89M 0.03% 369
2018
Q2 		$6.71M Buy
28,199
+8,902
+46% +$2.06M 0.58% 45
2018
Q1 		$4.24M Sell
19,297
-626
-3% -$147K 0.39% 66
2017
Q4 		$4.48M Sell
19,923
-5,402
-21% -$1.15M 0.38% 67
2017
Q3 		$4.81M Sell
25,325
-1,676
-6% -$319K 0.52% 49
2017
Q2 		$5.08M Buy
27,001
+12,890
+91% +$2.32M 0.48% 44
2017
Q1 		$2.33M Buy
+14,111
New +$2.24M 0.21% 109
2016
Q4 		– Sell
-6,814
Closed -$853K – 1002
2016
Q3 		$853K Sell
6,814
-17,250
-72% -$2.23M 0.07% 285
2016
Q2 		$3.16M Hold
24,064
– – 0.3% 64
2016
Q1 		$3.35M Hold
24,064
– – 0.31% 64
2015
Q4 		$3.35M Sell
24,064
-755
-3% -$104K 0.3% 84
2015
Q3 		$3.48M Sell
24,819
-9,806
-28% -$1.47M 0.34% 82
2015
Q2 		$5.68M Buy
34,625
+7,795
+29% +$1.25M 0.58% 30
2015
Q1 		$4.14M Buy
26,830
+1,380
+5% +$196K 0.44% 51
2014
Q4 		$3.2M Buy
+25,450
New +$3.14M 0.41% 71
2014
Q2 		– Sell
-83,725
Closed -$8.34M – 345
2014
Q1 		$8.34M Sell
83,725
-50,335
-38% -$4.55M 1.37% 17
2013
Q4 		$12.4M Buy
134,060
+9,495
+8% +$844K 2.12% 5
2013
Q3 		$10.4M Buy
124,565
+69,705
+127% +$5.97M 1.98% 5
2013
Q2 		$4.49M Buy
+54,860
New +$4.11M 0.89% 37

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Meeder Asset Management's ELV Position: Q1 2026 in Review

Meeder Asset Management reduced its Elevance Health (ELV) stake by 2.4% in Q1 2026, selling an estimated $156K and leaving 19,555 shares worth $5.72M. The position accounts for 0.33% of the portfolio, ranked #68.

Meeder Asset Management first reported a position in ELV in Q2 2013 and has held it in 48 quarters since. The position peaked at $24.4M in Q2 2024. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Meeder Asset Management held 19,555 shares of Elevance Health worth $5.72M as of Q1 2026.
  • Meeder Asset Management sold 476 Elevance Health shares in Q1 2026, an estimated $156K.
  • Elevance Health made up 0.33% of Meeder Asset Management's portfolio in Q1 2026, its #68 holding.
  • Meeder Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 48 quarters since.
  • Meeder Asset Management's Elevance Health position peaked at $24.4M in Q2 2024.
  • 1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.